Edition:
India

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

5.10USD
26 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.10
Open
$5.10
Day's High
$5.12
Day's Low
$5.10
Volume
6,417
Avg. Vol
179,224
52-wk High
$6.15
52-wk Low
$3.60

Chart for

About

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $430.73
Shares Outstanding(Mil.): 85.29
Dividend: --
Yield (%): --

Financials

BRIEF-Apollo Hospitals In India To Acquire Two Accuray Radixact Systems

* APOLLO HOSPITALS IN INDIA TO ACQUIRE TWO ACCURAY RADIXACT® SYSTEMS

28 Mar 2018

BRIEF-Accuray Retires February 2018 Convertible Notes

* ACCURAY RETIRES FEBRUARY 2018 CONVERTIBLE NOTES Source text for Eikon: Further company coverage:

05 Feb 2018

BRIEF-Accuray Reports Q2 Loss Per Share $0.06

* ACCURAY FISCAL SECOND QUARTER REVENUE EXCEEDS $100 MILLION AND INCREASES 15 PERCENT YEAR-OVER-YEAR; GROSS ORDERS OF $77.9 MILLION; BACKLOG UP 10 PERCENT

24 Jan 2018

BRIEF-Beverly Huss Joins Accuray Board Of Directors

* ACCURAY INC - WITH APPOINTMENT OF HUSS, CO'S BOARD CONSISTS OF SEVEN MEMBERS Source text for Eikon: Further company coverage:

12 Jan 2018

BRIEF-Accuray Elects Net Share Settlement For 3.50 Pct Series A Convertible Senior Notes

* ACCURAY ELECTS NET SHARE SETTLEMENT FOR 3.50% SERIES A CONVERTIBLE SENIOR NOTES DUE 2018

04 Jan 2018

Competitors

Earnings vs. Estimates